Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients.

Fakra E, Khalfa S, Da Fonseca D, Besnier N, Delaveau P, Azorin JM, Blin O.

Psychopharmacology (Berl). 2008 Oct;200(2):261-72. doi: 10.1007/s00213-008-1203-y. Epub 2008 Jun 25.

PMID:
18575849
2.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
3.

Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.

Fakra E, Salgado-Pineda P, Besnier N, Azorin JM, Blin O.

World J Biol Psychiatry. 2009;10(4 Pt 3):719-28.

PMID:
17853271
4.
5.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
6.

Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.

Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.

Psychopharmacology (Berl). 2004 Oct;175(4):473-80.

PMID:
15083259
7.

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.

Xiberas X, Martinot JL, Mallet L, Artiges E, Loc'H C, Mazière B, Paillère-Martinot ML.

Br J Psychiatry. 2001 Dec;179:503-8.

8.

Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.

Lataster J, van Os J, de Haan L, Thewissen V, Bak M, Lataster T, Lardinois M, Delespaul PA, Myin-Germeys I.

J Clin Psychiatry. 2011 Oct;72(10):1397-404. doi: 10.4088/JCP.09m05466yel.

PMID:
21208588
9.

Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloperidol.

Williams LM, Loughland CM, Green MJ, Harris AW, Gordon E.

Psychiatry Res. 2003 Aug 30;120(1):13-27.

PMID:
14500110
10.
11.

Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.

Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.

Addict Biol. 2009 Jul;14(3):283-93. doi: 10.1111/j.1369-1600.2008.00145.x. Epub 2009 Mar 5.

PMID:
19298320
12.

Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone.

Markianos M, Hatzimanolis J, Lykouras L.

Psychopharmacology (Berl). 1999 Apr;143(3):270-2.

PMID:
10353429
13.
14.

Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.

Reimold M, Solbach C, Noda S, Schaefer JE, Bartels M, Beneke M, Machulla HJ, Bares R, Glaser T, Wormstall H.

Psychopharmacology (Berl). 2007 Feb;190(2):241-9. Epub 2006 Nov 17.

PMID:
17111172
15.

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.

Kucharska-Pietura K, Tylec A, Czernikiewicz A, Mortimer A.

Med Sci Monit. 2012 Jan;18(1):CR44-49.

16.

Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.

See RE, Fido AA, Maurice M, Ibrahim MM, Salama GM.

Biol Psychiatry. 1999 Jun 15;45(12):1653-6.

PMID:
10376128
17.

Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.

Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.

J Psychiatr Res. 2008 Mar;42(4):328-35. Epub 2007 Apr 6.

PMID:
17412363
18.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
19.

Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments.

Scherer H, Bedard MA, Stip E, Paquet F, Richer F, Bériault M, Rodriguez JP, Motard JP.

Cogn Behav Neurol. 2004 Mar;17(1):32-40.

PMID:
15209223
20.

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.

Rémillard S, Pourcher E, Cohen H.

J Int Neuropsychol Soc. 2008 Jan;14(1):110-8.

PMID:
18078537
Items per page

Supplemental Content

Write to the Help Desk